Jally Biotechnology Co., Ltd., established in 2017, is a Sino Australian joint venture with a registered capital of 154million yuan. The company is headquartered in Hangzhou Bay New Area, Ningbo, a national economic and Technological Development Zone, covering an area of 26668 square meters. It is an animal medicine and health care product enterprise specializing in the R & D, production and operation of veterinary biological products, chemical products and diagnostic reagents. The company now has a GMP production workshop of more than 25000 square meters, a GCP experiment center and a quality inspection R & D center of 5000 square meters, equipped with modern automatic production lines and various scientific research instruments and facilities, and has a group of senior scientific research and management talents.

Jally Biotechnology Co., Ltd. has designed and constructed 12 production lines, including 4 chemical drugs, 1 oral liquid, 1 API synthesis and purification, 4 crude drugs and 2 diagnostic reagents. The production workshop has passed the GMP acceptance of veterinary drugs in accordance with European and American international standards and national veterinary drug GMP specifications. The R & D and quality inspection Animal Center will pass the CNAs and GCP certification.

Jally Biotechnology Co., Ltd. focuses on the R & D and production of economic animal breeding products, pet vaccines and health care products. The main products include: animal breeding products, animal disease prevention products, pet vaccine products, pet health products, etc. The company has established close cooperative relations with scientific research institutions and colleges and universities, such as China Agricultural University, Jallyn University, Jallyn Agricultural University, Zhejiang University, Institute of veterinary medicine, Chinese Academy of Military Sciences, Shanghai Institute of veterinary medicine, Chinese Academy of Agricultural Sciences, and has carried out comprehensive and in-depth research in the fields of economic animal breeding, synchronization of estrus, batch breeding, timed insemination technology, and animal prevention and treatment of zoonoses.

Jally Biotechnology Co., Ltd. is determined to become a leader in China's animal health industry. The employees of the company will adhere to the values of innovation, inclusiveness, ownership and trustworthiness, and are committed to continuously providing valuable products, services and talents for animal health customers, and continuously creating higher value for customers.